Research across more than 4 decades has produced numerous empirically tested evidence-based psychotherapies (EBPs) for psychopathology in children and adolescents. The EBPs were developed to improve on usual clinical interventions. Advocates argue that the EBPs should replace usual care, but this assumes that EBPs produce better outcomes than usual care.
A half-century of treatment development research has produced an array of evidence-based psychotherapies (EBPs) for children and adolescents (hereinafter referred to as youths). These EBPs-ie, treatments meeting multiple scientific criteria, including replicated support in randomized clinical trials (RCTs)-have been featured in numerous scholarly publications [1] [2] [3] and governmental and professional association and academy websites. 4, 5 Many researchers argue that EBPs should replace the usual treatments used in everyday clinical care. [6] [7] [8] Critics disagree, [9] [10] [11] [12] [13] arguing that EBPs (1) have been tested mainly in youths with subclinical problems and may not work well in those with more serious, complex, diagnosed disorders treated in real-world intervention settings; (2) are too rigidly manualized to permit the personalizing of treatment that professionals attempt in usual care; and (3) are mainly products of North American Western culture that may not travel well across ethnic, cultural, or national boundaries. Clearly, whether youth EBPs are superior or inferior to usual clinical care is subject to debate. This debate highlights a critical empirical question: When youth EBPs and usual care are compared directly, does one form of treatment produce superior outcomes? The question is important scientifically, but also practically and clinically. Given the substantial cost of implementing most EBPs-with proprietary manuals and measures and lengthy training and supervision often required-potential users may reasonably ask whether EBPs reliably outperform usual care, and if so to what extent. Most RCTs cannot answer this question because they have compared EBPs with waiting-list or no-treatment (passage of time) conditions, with attention-only control groups, or with psychological or medication placebo control groups.
2 Those comparison conditions are all designed specifically to be weaker than the active treatment, controlling only for the passage of time, attention paid to the patient, or patient expectancies, and are explicitly not designed to have beneficial therapeutic effects. By contrast, usual care is typically a stronger comparison condition because it entails an array of active interventions designed to produce genuine benefit to the patient. Thus, comparisons of EBPs with usual care are not only important scientifically and clinically, they also generally represent a stronger standard for testing EBPs than other control groups do. To apply this strong standard, we identified 52 RCTs in which youths were randomly assigned to EBPs or usual clinical care. This study collection is larger and meets more rigorous inclusion standards than any previous work on the topic.
14, 15 We conducted a meta-analysis of these 52 studies, assessing the effect of EBPs relative to usual care and testing candidate moderators of treatment benefit. To strengthen the analyses, we used a recently developed multilevel approach to research synthesis that has not previously been applied to psychotherapy research. This approach allowed us to model the dependency among effect sizes (ESs) that is common, but typically unaddressed, in psychotherapy metaanalysis.
Methods

Data Sources, Study Selection, Inclusion criteria
We searched for RCTs of youth psychotherapy that encompassed internalizing (eg, anxiety, depression) and externalizing (eg, misconduct, attention-deficit/hyperactivity disorder) dysfunction. 16, 17 Our first search used PsycINFO and
PubMed from January 1, 1960, through December 31, 2010. For PsycINFO, we used 21 psychotherapy-related key terms (eg, psychother-, counseling) from previous youth psychotherapy meta-analyses. 18, 19 The PubMed-controlled indexing system of Medical Subject Headings searches publishers who may use different keywords for the same concepts; we used mental disorders with the search limits clinical trial, child (3-18 years), published in English, and human subjects. Next, we searched reviews and meta-analyses of youth psychotherapy, followed reference trails, and obtained studies suggested by investigators in the field. Standard guidelines for performing meta-analyses [20] [21] [22] recommend addressing publication bias partly by including unpublished studies of acceptable methodological quality. Dissertations are particularly appropriate because they are (1) free of publication bias; (2) reliably identifiable through a systematic search of the Dissertation Abstracts International database; and (3) strong in methodological quality even compared with published studies (perhaps partly because dissertations require faculty committee supervision). 19 Therefore, we searched Dissertation Abstracts International using the same search terms as for the published literature search.
From the studies retrieved, we identified those that compared an EBP with a usual care intervention. Evidencebased psychotherapies were defined as treatments listed in at least 1 of the published reviews systematically identifying EBPs for youths based on the level of empirical support.
1,2,6,23-28 Usual care was defined as psychotherapy, counseling, or other nonmedication interventions provided through outpatient clinics, public programs and agencies (eg, child welfare, probation), or residential facilities (eg, inpatient, group home, detention) for youths. Usual care in which participants sought their own outside services were only included if the authors facilitated service use (eg, arranged intake appointments) or documented that equivalent percentages of participants in usual care and EBP groups (ie, not differing by more than 10%) received services. Other inclusion criteria were (1) participant psychopathology (mental disorder or elevated behavioral/emotional symptoms) documented through pretreatment and posttreatment assessment; (2) random assignment to treatment conditions; and (3) a mean age of 3 to 18 years. We defined psychopathology as meeting criteria for a DSM disorder (study years spanned DSM-II, DSM-III, and DSM-IV) or showing elevated behavioral/emotional symptoms because diagnostic and symptom approaches to operationally defining psychopathology are common in the youth treatment outcome literature. Youths who have elevated behavioral/ emotional symptoms experience serious impairment 1, 2, 29, 30 and are often referred to and treated in mental health 
The first-level equation (equation 1) indicates that the jth observed ES from study k equals its population value, plus a random deviation, which is assumed to be normally distributed. In a meta-analysis, this residual variance is estimated before performing the meta-analysis. The mean observed sampling variance of standardized mean difference was used in this study; it equaled 0.105. The second-level equation (equation 2) states that the population values comprise a study mean and random deviation from this mean, which is again assumed to be normally distributed. At the third level (equation 3), study mean effects are assumed to vary randomly around an overall mean.
We used this extension of the commonly used randomeffects meta-analytic model to obtain an overall estimate of the difference between EBP and usual care. Similarly to traditional mixed-effects models, we subsequently fitted a 3-level mixed-effects model to identify moderators that might explain variation in ESs within and between studies by adding study (level 3) or ES (level 2) characteristics as fixed predictors. Moderator analyses were only conducted if each category contained at least 3 studies. Because including multiple moderators with multiple categories may inflate type II error rates, 38 separate 3-level mixed models were fitted for each moderator variable. Afterward, we fitted a 3-level mixedeffects model that included moderators found to be significant in the separate models, to address possible confounding among moderators. Parameters estimated in a multilevel meta-analysis are the regression coefficients of the highest-level equations and the variances at the second and third level. Fixed-model parameters are tested using a Wald test, which compares the difference in parameter estimate and the hypothesized population value divided by the standard error with a t distribution. For categorical variables with more than 2 categories, the omnibus test of the null hypothesis that the group mean ESs are equal follows an F distribution. Likelihood ratio tests comparing the deviance scores of the full model and models excluding variance parameters were used to test variance components. Parameters were estimated using the restricted maximum likelihood procedure implemented in SAS PROC MIXED. 39 Observed ESs were weighted by the inverse of the sampling variance, with a general Satterthwaite approximation used for the denominator degrees of freedom for tests of the regression coefficients.
Publication Bias
We addressed risk of publication bias 22,40,41 in 4 ways. First, we included unpublished dissertations, as discussed above. Second, we compared the mean ES for published studies vs dissertations; the difference was not significant (t 53.9 = −0.70; P = .49). Third, we created a funnel plot 42 ; standard error was plotted on the vertical axis as a function of ES on the horizontal axis. The plot should resemble an inverted funnel with studies distributed symmetrically around the mean ES if publication bias is absent. With publication bias, the funnel plot should look asymmetrical. 40 Our plot, tested using the weighted regression test of Egger et al, 43 was not asymmetrical (t 50 = 0.76; P = .45). Fourth, we computed a classic fail-safe N value, 41 which showed that 565 studies with a mean ES of 0 would need to be added to yield a nonsignificant summary effect. This re-sult exceeded Rosenthal's 41 benchmark of 80 (5n + 10), suggesting that our findings are robust to the threat that excluded studies might have yielded a nonsignificant effect.
Methodological Rigor
Methodological rigor was assessed using the following risk of bias criteria suggested by the Cochrane Collaboration
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: (1) random sequence generation, (2) blinding of participants, and (3) completeness of outcome data (ie, attrition rate). Because less rigorous studies have been found to yield overestimates of ES, 44 we tested whether ESs differed according to the separate criteria. All studies passed the random sequence generation criterion, and we found no significant differences in mean ES on the blinding criterion (t 148 = −1.19; P = .24) or the completeness criterion (ie, attrition rate <40% [t 97 = −0.64; P = .52]).
Results
Study Pool
Our search yielded 52 RCTs (45 published trials and 7 dissertations) that met the inclusion criteria ( Figure) . These RCTs included 341 dependent ESs comparing EBPs with usual care. 3 studies included only a follow-up assessment. Of those studies reporting race/ethnicity, white youths were the majority in 22 and ethnic minorities in 15. More studies focused on adolescents (n = 37) than children (n = 15). Table 1 provides the other study characteristics.
Power
Given the novelty and complexity of the applied 3-level meta-analytic approach, a priori power calculation remains an understudied area. Therefore, we used the procedures of Borenstein et al 20 for standard meta-analysis for an approximate a priori estimate of power. Assuming a high level of between-study variance, a statistical power of 0.80, and an α value of .05, at least 32 studies with a mean sample size of 25 participants would be needed to detect a small overall ES (d = 0.20).
Difference Between EBP and Usual Care
Our 3-level model without moderators focused on the overall difference between EBP and usual care across the 341 dependent ESs retrieved from the 52 studies. The mean ES (d value) was 0.29 (95% CI, 0.19-0.38; t 47.7 = 5.95; P < .001). Effect sizes differed significantly between studies (σ v 2 = 0.096; χ 2 1 = 112.2; P< .001); differences between dependent ESs within studies were marginally significant (σ u 2 = 0.011; χ 2 1 = 3.5; P= .06). About 45% of the total ES variance was attributable to differences between studies and about 5% to differences within studies. To assess the effect of larger, more recent trials on the overall mean ES, we calculated the mean of the ES values for the 10 studies in the most recent decade with samples larger than 100; taking into account the multilevel structure of the data, their mean ES was 0.14 (95% CI, 0.02-0.26). This result did not suggest that including more of the larger modern trials would have increased the overall mean ES. Table 1 shows the mean ES for each of the 52 studies.
Moderator Analyses
Given the heterogeneity of ESs, moderator analyses were first conducted for each moderator separately to identify characteristics that might explain these differences; moderators found to be significant (P < .05) were then examined simultaneously to address confounding. Results of the first step, presented in Table 2 , are summarized herein.
Assessment Timing
Testing whether ES is smaller at follow-up than in the posttreatment period can shed light on the holding power of treatment effects. We found almost identical mean ESs for immediate posttherapy assessments and follow-up assessments a mean of 30.92 (SD, 18.74) weeks later. The number of weeks between the posttherapy assessment and follow-up was also not significantly associated with ES. In the 19 studies that included posttherapy and follow-up assessments, we found no significant effect of assessment time (t 51.8 = 0.20; P = .84) or the number of weeks since the end of therapy (t 67.4 = −0.19; P = .85). In summary, we found no evidence that effects were significantly weakened over time after treatment. 
Study Timing
Effect size was not related to study year (P = .61), and we did not find significant interactions of study year with the target problem (P = .67), type of EBP (P = .65), or developmental period (P = .51). The effect of study year was also not significant within any specific category of these moderators (eg, externalizing target problems; P > .30 for all).
Study Geographic Location
We tested whether the mean ES differed according to the region in which studies were conducted. Leading EBP researchers 6 have argued that EBPs are evidence based for particular groups and settings, not universally. Because most EBPs were originally developed and tested in North America, they may not fare as well when moved to other locations. Nine 
Research Original Investigation
Evidence-Based Psychotherapies vs Usual Care studies were conducted outside North America (6 in Europe, 2 in Australia, and 1 in Asia). Location showed a significant moderating effect, with lower ES for studies outside North America. Adding this moderator explained 10% of the between-study variance. Two possible explanations for this moderator effect might have been that the efficacy of EBP alone, or usual care alone, differed across countries. However, follow-up logistic regression models based on a logit link function showed no location effect on pretherapy-to-posttherapy gain (0 indicates no gain; 1, gain) for usual care (t 145 = −0.10; P = .92) or EBP (t 145 = −0.05; P = .96).
Sample Recruitment/Referral
We compared the mean ES for studies involving participants who were recruited (eg, through advertisements), clinically referred, and incarcerated. The groups did not differ significantly in mean ES. However, the mean ES for referred youths was modest (d = 0.17) and not statistically significant.
Other Study Variables
Sample Characteristics | We found no significant mean ES difference between studies in which EBP and usual care took place in the same vs different settings. Given that the EBPs were generally not originally designed for minority youths, we investigated whether the difference compared with usual care was smaller in ethnic minority samples than in white samples.
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The mean ES was somewhat lower for minority than majority samples, but not significantly so. To explore whether sex composition might moderate treatment effects, we tested whether the mean ES was significantly associated with the percentage of boys in the study samples. It was not. We also tested whether EBPs might be more effective with adolescents than children, as suggested by others. 112 The mean ES was more than twice as large for studies with adolescents (mean sample age, ≥12 years; d = 0.34) than studies with children (mean sample age, <12 years; d = 0.16), but we found no significant moderator effect. Notably, the mean ES for children was not statistically significant. We tested whether ES differed according to the form of youth mental health impairment (ie, internalizing, externalizing, or mixed). Results of the omnibus test were not significant.
Diagnosis | Leaders in the field 113 have suggested that EBP effects may be diminished in samples with more severe psychopathology. Indeed, the mean ES for studies that included only youths with psychopathology severe enough to meet DSM criteria was significantly lower than the mean ES for studies not requiring a diagnosis, and the mean ES for diagnosed samples was nonsignificant. Adding this moderator explained 30% of the between-study variance.
Informant | Some researchers have found that youths, parents, and other informants differ in their reports of youth improvement after treatment. 114, 115 In our omnibus test, the mean ES differed significantly by informant. Follow-up contrasts revealed a larger mean ES for youth report than teacher report (t 228 = 2.00; P = .047) and therapist report (t 228 = 3.46; P = .001).
The mean ES was also larger for parent report than therapist report (t 228 = 2.88; P = .004). Adding the informant moderator explained 27% of the between-study variance and 100% of the within-study variance.
Treatment Variables | The mean ES for parent/family-based treatments was somewhat lower than the mean ES for youthfocused, learning-based, multisystem, or combined treatments, but the difference was not significant. The mean ES was somewhat higher for usual system/agency services than for usual outpatient services and usual residential services; however, the difference among these usual care treatments was not significant. The mean ES was highest (d = 0.45) when treatment dose was higher for the EBP than the usual care condition, dropped markedly when dose was the same (d = 0.22), and dropped further still when dose was lower for EBP (d = 0.05). The mean ES was not significant in the latter 2 conditions. The pattern suggested that EBP superiority might be partially an artifact of larger treatment dose, but the omnibus test was only marginally significant. The dose × type of EBP interaction was also not significant (P = .27). The dose was not consistently reported and could be coded in only 23 of the 52 studies.
Investigator Allegiance | Following the example of several researchers, 15 we coded whether study authors had a likely allegiance to the EBP being tested based on whether or not the EBP developer was an author of the article or a committee member for the dissertation. Although the mean ES appeared somewhat larger when investigator allegiance was evident (d = 0.32 vs d = 0.21; both means were significant), the difference between them was not significant.
Addressing Confounding Among Moderators
Although moderators are the keys to explaining ES differences, moderators may not only be associated with ES but also with each other, complicating the interpretation of single-moderator effects. To address this issue, we simultaneously included all 3 moderators that had shown significant effects within a 3-level mixed-effects model to test the effect of each moderator holding the others constant. We also used a parsimonious modeling approach to test for interactions between moderators, adding possible interactions one at a time. Because results of the moderator analysis for the informant variable revealed similar mean ESs for youth and parent reports and for teacher and therapist reports, these pairs of categories were collapsed into youth or parent reports vs teacher or therapist reports to increase power. Missingness was also coded to reduce loss of information when modeling multiple moderators. The mean ES for the base category-EBP vs usual care comparisons reported by youths or parents from studies conducted in North America not requiring a diagnosis-was calculated as d = 0.43 (95% CI, 0.21-0.66; t 43.2 = 3.71; P < .001). The mean ESs decreased significantly when teachers or therapists were the informants (d = 0.22; t 331 = −2.29; P = .02) and nonsignificantly when studies were conducted outside North America (d = 0.25; t 44.6 = −1.42; P = .16) and when all participants received a formal diagnosis (d = 0.17; t 42.7 = −1.60; P = .12). We also found a significant study location × informant inter- 
Discussion
Our findings support the perspectives of both EBP proponents and critics. In support of the proponents who argue that EBPs should replace usual care, we found that EBPs produced better outcomes than usual care. The mean standardized difference of 0.29 was not only significant but rather durable as well. Effects at follow-up assessments a mean of 31 weeks after treatment ended were very similar to effects in the immediate posttreatment period, suggesting that the benefit of EBPs relative to usual care may last well beyond the end of treatment.
That said, the mean ES of d = 0.29 was modest, somewhat above the Cohen threshold 32 for a small effect and reflecting a probability of only 58% that a randomly selected youth receiving EBP would be better off after treatment than a randomly selected youth receiving usual care. 116 These findings suggest that (1) the youth EBPs that have been tested to date may be less potent than some have assumed, when pitted against active usual care treatments, and (2) some forms of usual care may be more potent than some have assumed. Indeed, a review of Table 1 reveals several instances in which certain forms of usual care outperformed EBPs. Moreover, the effects of EBPs varied widely, even the effects of the same EBP when tested in relation to different forms of usual care (eg, the variation for multisystemic therapy in Table 1 ). These variations in ES may also relate to trial design. Studies using tightly controlled efficacy designs might be expected to produce somewhat larger effects than studies using effectiveness designs in which EBPs are evaluated under more usual clinical practice conditions. Our findings appear to support some of the concerns raised by critics of EBPs 9-13 and noted in the introduction. The concern that EBPs have been tested mostly among youths with subclinical psychopathology and might not fare well among youths with the more serious, complex, diagnosed disorders seen in real-world treatment settings was supported by the low and nonsignificant ES values we found for studies using exclusively diagnosed samples (d = 0.09) and studies focused on clinically referred youths (d = 0.17). In addition, more severe cases may need medication, alone or in combination with psychotherapy. The concern that EBPs may not generalize well beyond their culture of origin was supported by our finding that EBPs, which looked relatively strong within studies in North America, where most EBPs were developed (d = 0.33), showed a much-diminished and nonsignificant effect in studies from other countries (d = 0.06). This finding suggests the potential value of cultural adaptation of treatments. 117 A third concern noted in the introduction-that EBPs are too rigidly manualized to permit the personalization that professionals can attempt in usual care-could not be tested directly in this metaanalysis, but the recent success of modular strategies for personalizing EBPs (eg, trial by Weisz and colleagues
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) suggests that this possibility bears study in the future. One further concern was raised by our finding that EBP effects that were significant for outcomes reported by the youths (d = 0.30) and parents (d = 0.24) who participated in therapy became nonsignificant for outcomes reported by teachers (d = 0.10), who were more likely to be blinded to treatment condition. These caveats may warrant attention by those considering the costs of implementing EBPs (described in the introduction) relative to the benefits.
Limitations of this meta-analysis suggest future directions. First, usual care interventions were not described in detail in most of the studies, making it difficult to characterize them precisely. The fact that some studies showed usual care matching or outperforming EBPs suggests that those usual care interventions may deserve further study in their own right. Second, additional research in the future will generate more EBP vs usual care comparisons, increasing power to detect additional moderators and interactions among them (eg, a properly powered test of whether the informant effect differs by target problem). Third, an interesting feature in research of this type is that EBP vs usual care studies tend to be carried out in programs, settings, and contexts where research is valued, or at least allowed. This preference might affect the meaning of findings in ways that are understood poorly at present, and findings might be different in clinical settings where research has low priority. Fourth, a growing body of research focuses on pharmacotherapy and its impact in relation to and in combination with youth psychotherapy; that research, not included here, could be a useful topic in its own right for future meta-analyses. Finally, usual care varies across studies and settings and in some instances could include some elements of empirically tested treatments, thus reducing the difference between EBPs and usual care in studies like those reviewed here. This variability further highlights the need for investigators to document thoroughly the contents of the usual care interventions they study.
Our findings show a modest advantage afforded by current EBPs and the limits of that advantage (eg, for youths with diagnosed disorders and those outside North America), which could be seen as a reality check for clinical scientists who develop EBPs for youths. The findings suggest a need in the years ahead to strengthen and broaden the benefit afforded by these treatments for youths and families who seek help. At a more fine-grained level, the accumulation of research in the future should make identification of specific EBPs that do and do not reliably outperform common forms of usual care increasingly possible. Findings at this level of specificity may be valuable to clinicians, clinical directors, and policy makers, helping to inform their decisions as to which EBPs offer sufficiently robust gains over usual care to justify the effort and expense of implementing them in practice. 
